Pegylated liposomal doxorubicin, an effective, well-tolerated treatment for refractory aggressive fibromatosis

European Journal of Cancer

Volumn 45, Issue 17, 2009, Pages 2930-2934

  Constantinidou, Anastasia ^a   Jones, Robin L ^a   Scurr, Michelle ^a   Al Muderis, Omar ^a   Judson, Ian ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Caelyx; Chemotherapy; Desmoid tumour; Fibromatosis; Pegylated liposomal doxorubicin

Indexed keywords

ASCORBIC ACID; CYCLOPHOSPHAMIDE; DICLOFENAC; DOXORUBICIN; IFOSFAMIDE; IMATINIB; METHOTREXATE; PREDNISONE; SULINDAC; TAMOXIFEN; TOREMIFENE; VINBLASTINE;

ABDOMINAL TUMOR; ADOLESCENT; ADULT; ANALGESIA; ARTICLE; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CHILD; CLINICAL ARTICLE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG TOLERABILITY; FATIGUE; FEMALE; FIBROMATOSIS; FOLLOW UP; HAND FOOT SYNDROME; HEAD AND NECK TUMOR; HUMAN; LIMB TUMOR; MALE; MONOTHERAPY; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NERVE TUMOR; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEX RATIO; SPINAL CORD TUMOR; THORAX TUMOR; THORAX WALL TUMOR; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR REGRESSION; WALKING DIFFICULTY;

ADOLESCENT; ADULT; ANTIBIOTICS, ANTINEOPLASTIC; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; DOXORUBICIN; DRUG ADMINISTRATION SCHEDULE; FEMALE; FIBROMATOSIS, AGGRESSIVE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; POLYETHYLENE GLYCOLS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 70350600583     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2009.08.016     Document Type: Article

References (15)

1. Pikaar A., Nortier J.W.R., Griffioen G., and Vasen H.F.A. Desmoid tumours in patients with familial adenomatous polyposis (FAP). NTvG 146 29 (2002) 1355-1359
2. Tejpar S., Nollet F., Li C., et al. Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor). Oncogene 18 (1999) 6615-6620
3. Lev D., Kotilingam D., Wei C., et al. Optimizing treatment of desmoids tumors. J Clin Oncol 25 13 (2007) 1785-1791
4. Patel S.R., and Benjamin R.S. Desmoid tumors respond to chemotherapy: defying the dogma in oncology. J Clin Oncol 24 (2006) 11-12
5. Hansmann A., Adolph C., Vogel T., Unger A., and Moeslein G. High-dose tamoxifen and sulindac as first-line treatment for desmoid tumors. Cancer 100 (2004) 612-620
6. Weiss A.J., Horowiz S., and Lackman R.D. Therapy of desmoid tumors and fibromatosis using vinorelbine. Am J Clin Oncol 22 (1999) 193-195
7. Okuno S.H., and Edmonson J.H. Combination chemotherapy for desmoid tumors. Cancer 97 (2003) 134-135
8. Gega M., Yanagi H., Yoshikawa R., et al. Successful chemotherapeutic modality of doxorubicin plus dacarbazine for the treatment of desmoids tumors in association with familial adenomatous polyposis. J Clin Oncol 24 (2006) 102-105
9. Poritz L.S., Blackstein M., Berk T., Gallinger S., McLeod R.S., and Cohen Z. Extended follow-up of patients treated with cytotoxic chemotherapy for intra-abdominal desmoids tumors. Dis Colon Rectum 44 (2001) 1268-1273
10. Wehl G., Rossler J., Otten J.E., et al. Response of progressive fibromatosis to therapy with liposomal doxorubicin. Onkologie 27 6 (2004) 526-552
11. Van Dalen EC, Michiels EMC, Caron HN, Kremer LCM. Different anthracycline derivates for reducing cardiotoxicity in cancer patients. Cochrane Database Syst Rev 2006; Issue 4. Art. No.: CD005006. doi: 10.1002/14651858.CD005006.pub2.
12. Eisenhauer E.A., Therasse P., Bogaerts J., et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45 2 (2009) 228-247
13. Pilz T., Pilgrim T.B., Bisogno G., et al. Chemotherapy in fibromatoses of childhood and adolescence: results from the cooperative soft tissue sarcoma study (CWS) and the Italian Cooperative study group (ICG-AIEOP). Klin Padiatr 211 (1999) 291-295
14. Skapec S.X., Hawk B.J., Hoffer F.A., et al. Combination chemotherapy using vinblastine and methotrexate for the treatment of progressive desmoid tumor in children. J Clin Oncol 16 (1998) 3021-3027
15. Heinrich M.C., McArthur G G.A., Demetri G.D., et al. Clinical and molecular studies of the effect of imatinib on advanced aggressive fibromatosis (desmoid tumor). J Clin Oncol 24 (2006) 1195-1203